Latest News & Features
Big Pharma
The Court of Justice of the European Union yesterday, March 21, handed down a supplementary protection certificate decision referred to it by the English High Court. 22 March 2019
Big Pharma
Seven new drugs are forecasted to achieve annual sales of $1 billion or more by 2023, according to a new report. 21 March 2019
Africa
World Health Organization (WHO) experts have called for central registry on human genome editing research is needed, among a committee consensus that it would be irresponsible for any scientist to conduct gene-editing studies in people. 21 March 2019
Europe
The EU General Court yesterday, March 20, annulled a European Union Intellectual Property Office (EUIPO) decision and handed a trademark victory to Spain-based Prim. 21 March 2019
Big Pharma
Allergan and the Saint Regis Mohawk Tribe have again urged the US Supreme Court to hear their closely-followed litigation on tribal sovereign immunity, following a submission from generic maker Mylan in the case. 20 March 2019
Big Pharma
The US Supreme Court will seek the advice of the country’s solicitor general after it agreed to hear an appeal in a dispute over whether a medical treatment is directed towards a natural law. 19 March 2019
Americas
Danish pharmaceutical company Novo Nordisk and generics maker Teva have reached a settlement in their US dispute over Victoza. 19 March 2019
Americas
The US Court of Appeals for the Federal Circuit has warned against implementing “too broad” an interpretation of the Alice test as it ruled that “treatment claims” were eligible for patenting. 18 March 2019
Big Pharma
A district court must revisit its decision that one of Allergan’s patents is valid and was not infringed by a competitor. 18 March 2019
Americas
Supranational organisations such as the World Health Organization and the United Nations Development Program are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents. 18 March 2019